Multiplex Biomarker Imaging Market - Global Industry Analysis
Multiplex Biomarker Imaging Market by Application (Drug Safety, Oncology Studies, and Genetic Characterization Studies), by Imaging Techniques (Immuno Fluorescence (IF) Assay, Tissue Microarray (TMA) Assay, Immunohistochemistry (IHC) Assay, Fluorescent in the Situ Hybridization (FISH) Assay, and Toponome Imaging System (TIS)), and by End-User (Research Institutes Government & Private, Clinical Labs, and Pharmaceutical & Biotechnology): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 – 2024
Published Date: 12-Sep-2018Healthcare
Category: Report Format : PDF
Report Code: ZMR-1670
Status : Published
Global multiplex biomarker imaging market expected to generate revenue of around USD 608.2 million by end of 2024, growing at a CAGR of around 12.3% between 2018 and 2024. Increasing demand for analysis of the diseases and imaging has accelerated the growth of the multiplex biomarker imaging market over the estimated time.